Search

Disclaimer

Page

… are initiated, the actual timing and results of the (pre)clinical trials, the actual timing and content of regulatory …
Science

Page

At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
Privacy

Page

… us, applying for available vacancies, registering to clinical trial updates, getting updates on the company or subscribing …
Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene

Presentation

ARVO 2020 clinical trial results presentation by Stephen Russel et al. Sepofarsen had a manageable safety profile and showed improvement in mean visual acuity, and full-field stimulus testing.

June 17, 2020

Results (1 to 4 of 4)